Leadership & Pay ·
Davion Healthcare names Glenn Williams CEO ahead of expected Nasdaq listing on Oct 22
DAVIDavion Healthcare PLC
Davion Healthcare Plc announced that ordinary shares will commence trading on the Nasdaq Global Market under ticker "DAVI" on October 22, 2026. Concurrently, the company appointed Glenn Williams as Chief Executive Officer and Jeremy North as Chief Operating Officer, effective upon the start of trading. Current CEO Jack Kaye transitions to Chairman, while Sir Eric Peacock steps down as Chairman but remains a Non-Executive Director. Davion is establishing an Operational Directorate led by Williams to drive commercialization of its flagship BreastCheck product and pursue acquisitions. The company operates in the digital healthcare sector, developing non-invasive health monitoring technologies.